These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1461300)

  • 21. Rapid pre-screening of Pap smears in quality control: an Italian experience.
    Placidi A; Manca G; Mania E; Arbyn M
    Cytopathology; 2004 Apr; 15(2):121-3. PubMed ID: 15056176
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of the agreement between cytological and histological examinations in the diagnosis of cervical cancer].
    Kujawska E; Waszyński E
    Wiad Lek; 1981 Aug; 34(15):1263-6. PubMed ID: 7331327
    [No Abstract]   [Full Text] [Related]  

  • 23. Atypical squamous cells in Papanicolaou smears.
    Davis GL; Hernandez E; Davis JL; Miyazawa K
    Obstet Gynecol; 1987 Jan; 69(1):43-6. PubMed ID: 3540762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality control and automation in cervical cytology.
    Kumar N; Jain S
    J Indian Med Assoc; 2004 Jul; 102(7):372, 374, 376 pasim. PubMed ID: 15717583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pitfalls in diagnostic cervicovaginal cytology.
    Sidawy MK; Solomon D
    Monogr Pathol; 1997; (39):1-15. PubMed ID: 9249817
    [No Abstract]   [Full Text] [Related]  

  • 26. Liability issues with the Papanicolaou smear: a defense lawyer's perspective.
    Varner CD
    Arch Pathol Lab Med; 1997 Mar; 121(3):315-20. PubMed ID: 9111126
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cervical cancer screening. False negative smears].
    Vassilakos P; De Marval F; Muñoz M
    Rev Med Suisse Romande; 1997 Aug; 117(8):597-601. PubMed ID: 9340714
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of the cervical cytology test using the PAPNET method and conventional microscopy.
    Weissbrod D; Torres M; Rodríguez A; Ureña I; Estrada J; Reyes ME; Carreto AJ
    Bull Pan Am Health Organ; 1996 Dec; 30(4):339-47. PubMed ID: 9041745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reducing the error rate in Papanicolaou smears. One laboratory's experience with the PAPNET system.
    Koss LG
    Physician Assist; 1994 Dec; 18(12):48-52. PubMed ID: 10139375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. False negative rate in mass screening for cervical cancer.
    Sato S; Mikino H; Matsunaga G; Yajima A
    Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728
    [No Abstract]   [Full Text] [Related]  

  • 31. [Analysis of the intralaboratory diagnostic variability in the Imola cervical screening program].
    Fabbris E; Bucchi L; Folicaldi S; Amadori A; Ghidoni D; Medri M; Bondi A
    Pathologica; 1998 Apr; 90(2):127-32. PubMed ID: 9619055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [False negative Pap smears in a Danish material].
    Ejersbo D; Dahl MB; Hølund B
    Ugeskr Laeger; 2003 Jun; 165(23):2391-4. PubMed ID: 12840998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudo-decidual reaction to Mirena coil in a cervical smear: a potential diagnostic pitfall for false-positive cervical cytology.
    Hughes C; Woods J; Turner L; Gibbons D
    Cytopathology; 2005 Oct; 16(5):268-9. PubMed ID: 16181320
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cervical smears unsuitable for exclusion of cervical carcinoma].
    Giard RW; Blok P
    Ned Tijdschr Geneeskd; 2000 Jan; 144(2):86-7. PubMed ID: 10674109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Partial re-screening of all negative smears. A method of quality control of pathology department concerning smear screening against cervix cancer].
    Jensen ML; Dybdahl H; Svanholm H
    Ugeskr Laeger; 2000 May; 162(21):3024-7. PubMed ID: 10850190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How preventable is invasive cervical cancer? A community study of preventable factors.
    Martin PL
    Trans Pac Coast Obstet Gynecol Soc; 1971; 39(0):114-21. PubMed ID: 5164820
    [No Abstract]   [Full Text] [Related]  

  • 37. Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer.
    Kristensen GB; Skyggebjerg KD; Hølund B; Holm K; Hansen MK
    Acta Cytol; 1991; 35(1):47-50. PubMed ID: 1994634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellularity of liquid-based, thin-layer cervical cytology.
    Zardawi IM
    Acta Cytol; 2003; 47(5):943. PubMed ID: 14526685
    [No Abstract]   [Full Text] [Related]  

  • 39. HPV: from the cervical smear to the research bench to the court room.
    Atkins K
    Clin Leadersh Manag Rev; 2003; 17(6):341-5. PubMed ID: 14692078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Histopathological verification of the cervical pap smears based on material of the obstetrical-gynecological department of the provincial hospital in Kielce].
    Starzewski J; Góźdź S; Polak G; Piasek G; Laskawska M; Anisiewicz A; Adamczyk K
    Wiad Lek; 1999; 52(3-4):158-63. PubMed ID: 10499026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.